From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients

Eichler, H‐G; Baird, LG; Barker, Richard; Bloechl‐Daum, Brigitte; Børlum Kristensen, Finn; S. Brown, Jeffrey; Chua, Rachel; Del Signore, Susanna; Dugan, Ute; Ferguson, John; Garner, S; Goettsch, Wim; R.M. Haigh, Jeremy; K. Honig, Peter; Hoos, Anton; Huckle, P; Kondo, Tatsuya; Le Cam, Yann; G. M. Leufkens, Hubert; Lim, Robyn; Longson, Carole; Lumpkin, Murray; M. Maraganore, John; O’Rourke, Brian; A. Oye, Kenneth; J. Pezalla, Edmund; Pignatti, Francesco; Raine, June; Rasi, Guido; Salmonson, Tomas; Samaha, Dima; Schneeweiß, Sebastian; Siviero, PD; Skinner, Matthew; Russell Teagarden, J.; Tominaga, Toshiyoshi; Trusheim, MR; Tunis, Sean; F Unger, T; Vamvakas, Spiros; Hirsch, Gigi

doi:10.1002/cpt.59

Public

From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients

Published in Clinical Pharmacology & Therapeutics • Feb 4, 2015

Authors:

H‐G Eichler

LG Baird

Richard Barker

Abstract

The concept of adaptive licensing (AL) has met with considerable interest. Yet some remain skeptical about its feasibility. Others argue that the focus and name of AL should be broadened. Against this background of ongoing debate, we examine the environmental changes that will likely make adaptive p...

Subject

Risk analysis (engineering)

Sustainability

Business

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!